Society of Toxicologic Pathology (STP) - Comment

Document ID: FDA-2011-D-0872-0009
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: March 25 2012, at 12:00 AM Eastern Daylight Time
Date Posted: April 12 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: December 30 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: March 29 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80fe084e
View Document:

This is comment on Notice

Draft Guidance for Industry on Use of Histology in Biomarker Qualification Studies; Availabilty

View Comment

The Society of Toxicologic Pathology (STP) appreciates the opportunity to provide a response to the FDA draft guidance document, Use of Histology in Biomarker Qualification Studies. The STP is a nonprofit association of pathologists and other scientists whose principal aim is the advancement of pathology as it pertains to changes elicited by pharmacological, chemical, or environmental agents, and factors that modify these responses. The STP provides expert guidance to legislative and regulatory decision makers regarding toxicologic pathology data and human or animal health. Please see that attached file for our comments.

Attachments:

Society of Toxicologic Pathology (STP) - Comment STP letter_FDA_2011_D_0872

Title:
Society of Toxicologic Pathology (STP) - Comment STP letter_FDA_2011_D_0872

View Attachment: